|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Marina Biotech
| | | Phone: | (626) 964-5788 | Year Established: | 1983 | Ticker: | MRNA | Exchange: | OTCQB | Main Contact: | Joseph W. Ramelli, Chairman & CEO | | Other Contacts: | Erik Emerson, CCO Mihir Munsif, COO Seymour Fein, MD, CMO Falguni Trieu, Director of Business Development Larn Hwang, Ph.D., CSO
| | Company Description | Marina Biotech's, formerly MDRNA, focus is to treat the intersection of arthritis, pain, hypertension, and oncology diseases using combination therapies of already approved drugs. The company is developing and commercializing late stage, non-addictive pain therapeutics. The company’s ‘next-generation of celecoxib,’ including IT-102 and IT-103, are designed to control the dangerous side-effect of edema that prohibits the drug from being prescribed at higher doses. These have the potential of replacing opioids and combatting the opioid epidemic. Additionally we are developing therapeutic microbiome using the only orally bioavailable siRNAs platform against FAP and IBD. | |
|
|
|
|
|